Affymax and Takeda Report Phase 2 Analyses of Hematide(TM)/peginesatide in ... - MarketWatch (press release) Print
MarketWatch (press release)"Our goal with Hematide is to provide physicians with a convenient alternative treatment option to help manage anemia in people with chronic renal failure.

... read more